CB2 and GPR55 receptors as therapeutic targets for systemic immune dysregulation

Juan Zhou, Ian Burkovskiy, Hyewon Yang, Joel Sardinha, Christian Lehmann

Research output: Contribution to journalShort surveypeer-review

29 Citations (Scopus)

Abstract

The endocannabinoid system (ECS) is involved in many physiological processes and has been suggested to play a critical role in the immune response and the central nervous system (CNS). Therefore, ECS modulation has potential therapeutic effects on immune dysfunctional disorders, such as sepsis and CNS injury-induced immunodeficiency syndrome (CIDS). In sepsis, excessive release of pro- and anti-inflammatory mediators results in multi-organ dysfunction, failure, and death. In CIDS, an acute CNS injury dysregulates a normally well-balanced interplay between CNS and the immune system, leading to increased patients' susceptibility to infections. In this review, we will discuss potential therapeutic modulation of the immune response in sepsis and CNS injury by manipulation of the ECS representing a novel target for immunotherapy.

Original languageEnglish
Article number264
JournalFrontiers in Pharmacology
Volume7
Issue numberAUG
DOIs
Publication statusPublished - Aug 22 2016

Bibliographical note

Publisher Copyright:
© 2016 Zhou, Burkovskiy, Yang, Sardinha and Lehmann.

ASJC Scopus Subject Areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'CB2 and GPR55 receptors as therapeutic targets for systemic immune dysregulation'. Together they form a unique fingerprint.

Cite this